Crescent Maritime Health

CFBANQUE Investment confirms the AA rating assigned to Crescent Maritime Health (PRP2458.NX), an operator in the Maritime & Ports sector based in Namibia. This credit opinion reflects a superior credit quality, reflecting a very strong capacity to honour its financial obligations even under an adverse macroeconomic environment.

From a fundamental standpoint, the issuer posts an EBITDA margin of 34.7% which sits at the upper end of the sector range and evidences robust pricing power and exhibits a contained net leverage of 0.31x EBITDA, providing comfortable headroom to absorb capital expenditure and debt servicing. With revenues of $8.91B and a market capitalisation of $131M, Crescent Maritime Health commands a focused economic footprint within its domestic market.

Our proprietary models assign a Debt Capacity score of 824/1000, an Investment score of 584/1000 and an ESG & Governance score of 440/1000, reflecting a solid debt coverage, a measured investment potential and governance workstreams that need to be deepened.

The Stable outlook indicates that our committee does not anticipate, in its central scenario, a revision of the rating over a 12 to 18 month horizon. This analysis stems from the combined review of our quantitative models and the qualitative judgement of the CFBANQUE Investment rating committee, and may be updated in line with the evolution of fundamentals or the regional macroeconomic environment.